U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
178891178891Using Iron Supplementation to Decrease Iron Deficiency Anemia in Infants and Young Children in IndiaCompletedNo Results AvailableAnemiaDrug: iron supplement, iron dropshttps://ClinicalTrials.gov/show/NCT00213161
178892178892Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory DysfunctionCompletedNo Results AvailableAnovulationDrug: Anastrozole 1mg|Drug: Anastrozole 5mg dose|Drug: Anastrozole 10mg dose|Drug: Clomiphene Citrate 50mghttps://ClinicalTrials.gov/show/NCT00213148
178893178893A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)CompletedHas ResultsMultiple Sclerosis, Relapsing-RemittingDrug: Cladribine 5.25 mg/kg|Drug: Cladribine 3.5 mg/kg|Other: Placebohttps://ClinicalTrials.gov/show/NCT00213135
178894178894Effects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With InsulinCompletedNo Results AvailableType 2 Diabetes MellitusDrug: miglitolhttps://ClinicalTrials.gov/show/NCT00213122
178895178895Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin TreatmentCompletedNo Results AvailableType 1 Diabetes MellitusDrug: Miglitolhttps://ClinicalTrials.gov/show/NCT00213109
178896178896Effects of Hormonal Contraceptives on Liver Proteins and Coagulation Factors: A Comparison of a Contraceptive Vaginal Ring and an Oral ContraceptiveCompletedNo Results AvailableContraceptionDrug: Nestorone/ethinyl estradiol contraceptive vaginal ring; levonorgestrel/ethinyl estradiol oral contraceptivehttps://ClinicalTrials.gov/show/NCT00213096
178897178897Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV TransmissionCompletedNo Results AvailableHIV Infections|AIDS|Sexually Transmitted Diseases|HIV SeroconversionDrug: Carraguard (PC-515)https://ClinicalTrials.gov/show/NCT00213083
178898178898Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin TreatmentCompletedNo Results AvailableType 2 Diabetes MellitusDrug: Miglitolhttps://ClinicalTrials.gov/show/NCT00213070
178899178899Safety and Acceptability of Carraguardâ„¢ Among HIV-Negative Couples in ThailandCompletedNo Results AvailableHIV Infections|Chlamydia Trachomatis|Nesseria Gonorrhea|Trichomonas Vaginitis|SyphilisDrug: Carraguard (PC-515)https://ClinicalTrials.gov/show/NCT00213057
178900178900A Randomized, Controlled, Cross-Over Trial of Safety of Vaginal Use of Carraguard by HIV-Infected WomenCompletedNo Results AvailableHIV InfectionsDrug: Carraguard (PC-515)https://ClinicalTrials.gov/show/NCT00213044
178901178901Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible MicrobicideCompletedNo Results AvailableHIV Infections|Chlamydia Trachomatis|Neisseria Gonorrhoeae|Trichomonas Vaginitis|Syphilis|Herpes SimplexDrug: Carraguard (PC-515)https://ClinicalTrials.gov/show/NCT00213031
178902178902Safety, Acceptability and Preliminary Effectiveness of Carraguardâ„¢ (PC-515) in Preventing HIV/STI TransmissionCompletedNo Results AvailableHIV Infections|Chlamydia Trachomatis|Neisseria Gonorrhoeae|Trichomonas Vaginitis|SyphilisDrug: Carraguard (PC-515)https://ClinicalTrials.gov/show/NCT00213018
178903178903Safety and Acceptability of Carraguard® in HIV Positive Women and MenCompletedNo Results AvailableHIV InfectionsDrug: Carraguard (PC-515)https://ClinicalTrials.gov/show/NCT00213005
178904178904Biphasic Defibrillation Study: Trial to Compare Fixed Versus Escalating EnergyCompletedNo Results AvailableCardiac ArrestProcedure: fixed versus escalating biphasic defibrillationhttps://ClinicalTrials.gov/show/NCT00212992
178905178905Measuring Kidney Function in Kidney TransplantationCompletedNo Results AvailableRenal Transplanthttps://ClinicalTrials.gov/show/NCT00212979
178906178906Shared Mental Health Care Linking Mental Health Services With Family Medicine GroupsCompletedNo Results AvailablePsychosocial Factorshttps://ClinicalTrials.gov/show/NCT00212966
178907178907OPALS Critical Care Sub-StudiesCompletedNo Results AvailableCardiac ArrestProcedure: Advanced Life Supporthttps://ClinicalTrials.gov/show/NCT00212953
178908178908Supportive Therapy for Adherence to ART(STAART)CompletedNo Results AvailableHIV InfectionsBehavioral: Supportive Therapy for Adherence to ART (behavior)https://ClinicalTrials.gov/show/NCT00212940
178909178909Continuity of Care and Outcomes After Discharge From HospitalCompletedNo Results AvailablePatient Safetyhttps://ClinicalTrials.gov/show/NCT00212927
178910178910Increasing Screening for Type 2 Diabetes in Women With Previous Gestational Diabetes.CompletedNo Results AvailableGestational DiabetesBehavioral: Reminder letterhttps://ClinicalTrials.gov/show/NCT00212914
178911178911High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB TherapyCompletedNo Results AvailableDiabetic Kidney DiseaseDrug: High dose ACE-I vs ARBhttps://ClinicalTrials.gov/show/NCT00212901
178912178912Combination Vaccination Before HIV Treatment InterruptionCompletedNo Results AvailableHIV InfectionsBiological: Remune and ALVAChttps://ClinicalTrials.gov/show/NCT00212888
178913178913A Study of Four Dosing Regimens of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. Protocol Addendum: Extension Study of Maintenance Therapy of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease.CompletedNo Results AvailableChronic Kidney Disease|AnemiaDrug: epoetin alfahttps://ClinicalTrials.gov/show/NCT00212875
178914178914Dosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients With Chemotherapy Induced AnemiaCompletedNo Results AvailableAnemia|CancerOther: Patients with chemotherapy induced anemiahttps://ClinicalTrials.gov/show/NCT00212862
178915178915Autologous Chondrocyte Implantation in the Patellofemoral JointCompletedNo Results AvailableChondrosis|Patellar Articular Cartilage Lesions|Trochlear Articular Cartilage Lesionshttps://ClinicalTrials.gov/show/NCT00212849
178916178916Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817)CompletedNo Results AvailableSchizophreniaDrug: asenapine|Drug: olanzapinehttps://ClinicalTrials.gov/show/NCT00212836
178917178917The Effectiveness of Almotriptan Malate (AXERT®) 12.5 Milligrams When Taken at the Onset of Migraine PainCompletedNo Results AvailableMigraineDrug: almotriptan malatehttps://ClinicalTrials.gov/show/NCT00212823
178918178918Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache.CompletedNo Results AvailableMigraine|Headache|Classic Migraine|Common MigraineDrug: Topiramatehttps://ClinicalTrials.gov/show/NCT00212810
178919178919A Study to Determine the Efficacy and Safety of 2 Doses of Org 34517 as Adjunctive Therapy in Subjects With Psychotic Major Depression (28130)(P05845)CompletedNo Results AvailableDepression|Depressive Disorders|Psychotic DisordersDrug: Org 34517|Drug: Org 34517|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00212797
178920178920Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)CompletedNo Results AvailableSchizophrenia|Schizoaffective DisorderDrug: asenapine|Drug: olanzapinehttps://ClinicalTrials.gov/show/NCT00212784

* Görseller ve İçerik tekif hakkına sahip olabilir